These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7618436)

  • 1. Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study.
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Acta Neuropathol; 1995; 89(5):391-8. PubMed ID: 7618436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies on sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses.
    Haltia M; Tyynelä J; Baumann M; Henseler M; Sandhoff K
    Gerontology; 1995; 41 Suppl 2():239-48. PubMed ID: 8821335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL).
    Tyynelä J; Suopanki J; Baumann M; Haltia M
    Neuropediatrics; 1997 Feb; 28(1):49-52. PubMed ID: 9151322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinosis (INCL).
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Am J Med Genet; 1995 Jun; 57(2):294-7. PubMed ID: 7668348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis.
    Palmer DN; Tyynelä J; van Mil HC; Westlake VJ; Jolly RD
    J Inherit Metab Dis; 1997 Mar; 20(1):74-84. PubMed ID: 9061571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis.
    Tyynelä J; Palmer DN; Baumann M; Haltia M
    FEBS Lett; 1993 Sep; 330(1):8-12. PubMed ID: 8370464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.
    Nijssen PC; Ceuterick C; van Diggelen OP; Elleder M; Martin JJ; Teepen JL; Tyynelä J; Roos RA
    Brain Pathol; 2003 Oct; 13(4):574-81. PubMed ID: 14655761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease).
    Palmer DN; Jolly RD; van Mil HC; Tyynelä J; Westlake VJ
    Neuropediatrics; 1997 Feb; 28(1):45-8. PubMed ID: 9151321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry.
    Tyynelä J; Suopanki J; Santavuori P; Baumann M; Haltia M
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):369-75. PubMed ID: 9100667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographic heterogeneity of amyloid B-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein.
    Wisniewski KE; Maslinska D; Kitaguchi T; Kim KS; Goebel HH; Haltia M
    Acta Neuropathol; 1990; 80(1):26-34. PubMed ID: 1694383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of neuronal perikaryal spheroids in neuronal ceroid lipofuscinoses (Batten disease).
    Elleder M; Tyynela J
    Clin Neuropathol; 1998; 17(4):184-9. PubMed ID: 9707331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders.
    Elleder M; Sokolová J; Hrebícek M
    Acta Neuropathol; 1997 Apr; 93(4):379-90. PubMed ID: 9113203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine neuronal ceroid lipofuscinosis.
    Url A; Bauder B; Thalhammer J; Nowotny N; Kolodziejek J; Herout N; Fürst S; Weissenböck H
    Acta Neuropathol; 2001 Apr; 101(4):410-4. PubMed ID: 11355313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urine concentration of subunit c of mitochondrial ATP synthase in neuronal ceroid lipofuscinoses patients.
    Wisniewski KE; Golabek AA; Kida E
    J Inherit Metab Dis; 1994; 17(2):205-10. PubMed ID: 7967475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-protein immunoreactivity in brains of patients with neuronal ceroid lipofuscinosis: ultrastructural and biochemical demonstration.
    Kitaguchi T; Wisniewski KE; Maslinski S; Maslinska D; Wisniewski TM; Kim KS
    Neurosci Lett; 1990 May; 112(2-3):155-60. PubMed ID: 2193254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain lysosomal hydrolases in neuronal ceroid-lipofuscinoses.
    Prasad VV; Pullarkat RK
    Mol Chem Neuropathol; 1996; 29(2-3):169-79. PubMed ID: 8971694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.